Primary Peritoneal Carcinoma Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00814086Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerTreatment
NCT02217956Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary AdenocarcinomaTreatment